NEUROBO PHARMACEUTICALS INC (NRBO)

US64132R4048 - Common Stock

3.06  -0.04 (-1.29%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 2023
(2023-12-31)		 2022
(2022-12-31)		 2021
(2021-12-31)		 2020
(2020-12-31)		 2019
(2019-12-31)
ASSETS
Current Assets
Cash Equivalents
22.43M33.36M16.39M10.09M13.91M
Other Current Assets
77.00K170.00K200.00K600.00K210.00K
Total Current Assets
22.51M33.53M16.58M10.68M14.12M
 
Non-Current Assets
PPE Net
248.00K0.00220.00K290.00K350.00K
Other Non-Current Assets
21.00KN/AN/AN/AN/A
Total Non-Current Assets
269.00K0.00220.00K290.00K350.00K
 
TOTAL ASSETS
22.78M33.53M16.80M10.97M14.47M
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.000.00
Current Portion Of LT Debt.
N/AN/AN/AN/AN/A
Accrued Expenses
4.48M280.00K1.33M1.12M1.44M
Accounts Payable
821.00K710.00K830.00K2.58M640.00K
Other Current Liabilities
658.00K10.80MN/AN/AN/A
Total Current Liabilities
5.96M11.78M2.16M3.70M2.08M
 
Non-Current Liabilities
Long Term Debt
0.000.000.000.000.00
Other Non-Current Liabilities
136.00K0.0050.00K70.00K90.00K
Total Non-Current Liabilities
136.00K0.0040.00K70.00K100.00K
 
TOTAL LIABILITIES
6.10M11.78M2.20M3.77M2.18M
 
SHAREHOLDERS' EQUITY
Retained Earnings
-108.27M-95.80M-81.83M-66.54M-36.87M
Additional Paid In Capital
124.94M117.52M96.39M73.71M49.13M
Common Shares
5.00K30.00K30.00K20.00K20.00K
Other Shareholders' Equity
N/A0.000.0010.00K10.00K
Shares Outstanding
4.91M25.44M890.00K660.00K520.00K
Tangible Book Value per Share
3.400.8516.4010.9123.63
Total Shareholders' Equity
16.68M21.75M14.60M7.20M12.29M
 
TOTAL LIABILITIES AND EQUITY
22.78M33.53M16.80M10.97M14.47M
 
Statistics
Debt/Equity
N/AN/AN/AN/AN/A
Current Ratio
3.782.857.682.896.79
Return On Assets (ROA)
-54.74%-41.66%-90.95%-270.56%-147.27%
Return On Equity (ROE)
-74.74%-64.23%-104.66%-412.22%-173.39%

All data in USD

Charts